CBD
XPhyto announced significant progress with respect to development of its cannabidiol-(CBD) based epilepsy product.
The findings of this study showed that emotional intelligence training led to improvement of happiness in patients with epilepsy.
Pediatric Epilepsy
The team completed enrollment significantly ahead of schedule in the placebo-controlled Phase 2 ELEKTRA trial in children with Dravet syndrome and Lennox-Gastaut syndrome.
This model may be useful in better understanding the seizure count fluctuations seen in patients in other clinical settings.
Genetics, Pediatric Epilepsy
This month’s research highlights feature promising work by former CURE Grantees and CURE partners on SUDEP, treatment-resistant epilepsy, and more.
This will also allow people to receive the RNS System before committing to an irreversible surgery such as laser ablation, while keeping their future treatment options open.
SUDEP
This is the first study to explore the role of the amygdala and loss of breathing in children with epilepsy.
Tests of extracts from plants used in ancient remedies led to one compound, derived from a magnolia tree, which could quell drug-resistant seizures in both fish and mice.
The Phase 2b StATES study of Staccato® alprazolam met its primary endpoint which was proportion of responders achieving cessation of seizure activity within two minutes of treatment administration and no recurrence within two hours.
